<DOC>
	<DOCNO>NCT01585636</DOCNO>
	<brief_summary>This phase 1 , `` first man '' study evaluate single oral dos ( 5-300 mg ) SQ109 , new investigational drug develop treatment tuberculosis . If single dos safe well tolerate , subsequent study evaluate multiple daily dos healthy volunteer patient pulmonary tuberculosis .</brief_summary>
	<brief_title>Escalating Single-dose Safety , Tolerability , Pharmacokinetics SQ109 Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Tuberculosis</mesh_term>
	<criteria>1 . Subject must 18 55 year age . 2 . Subject must healthy male female volunteer ( i.e. , hematology , coagulation , clinical chemistry urinalysis test must within normal , allowable limit ) . Clinical laboratory test must perform within 21 day receive first dose study drug . 3 . Body weight must Â± 20 % ideal height estimate frame base 1983 Metropolitan Life Insurance Company table . 4 . Subject must give voluntary write informed consent study related procedure perform . 5 . Female subject postmenopausal , surgically sterile , agree use two form contraception screen 30 day dose study drug . All female subject childbearing potential must negative urine pregnancy test screening . 6 . Male subject must agree use acceptable barrier method birth control screen 30 day dose study drug . 1 . A history clinically significant gastrointestinal , renal , hepatic , neurologic , hematologic , endocrine , oncologic , pulmonary , immunologic , psychiatric , cardiovascular disease condition , opinion Investigator , would jeopardize safety subject impact validity study result . 2 . Subject abnormal diet 4 week precede study . Abnormal diet define diet subject significant change eat habit ( e.g. , liquid diet ) unbalance diet ( e.g. , protein , high fat , low carbohydrate , etc. ) . 3 . Subject donate blood within 30 day plasma within 14 day study dose . 4 . Subject participate clinical trial within 30 day prior study initiation ; herein , 30 day define 30 day last dosing clinical trial 5 . Subject use overthecounter ( OTC ) medication , include vitamin , within 7 day prior study . 6 . Subject use prescription medication within 14 day prior study . 7 . Subject treat known CYP450 enzyme alter drug azoles , antifungal , barbiturate , phenothiazine , cimetidine , carbamazepine , etc. , within 30 day prior study . 8 . Subject positive blood screen HIV , hepatitis B surface antigen ( HBsAg ) , hepatitis C antibody and/or positive urine screen alcohol drug abuse . 9 . Subject smoke used tobacco product within 2 month prior study . 10 . Subject uncontrolled intercurrent illness ( i.e. , active infection ) . 11 . Subject major surgery within 4 week study entry . 12 . Subject another serious medical psychiatric illness could , Investigator 's opinion , interfere completion treatment accord protocol . 13 . Subjects colorblind . 14 . Subjects QTc interval prolongation ( &gt; 450 msec ) history QTc interval prolongation . 15 . Subjects history alcohol abuse , drug and/or food allergy . 16 . Subjects intend consume grapefruit juice study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>SQ109</keyword>
	<keyword>Tuberculosis</keyword>
</DOC>